ATYR aTyr Pharma, Inc. Common Stock BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

aTyr Pharma (ATYR) Stock: Buy, Sell, or Hold?

$4.96
-0.28 (-5.34%) ▼
5d: -34.39% 30d: +2788.76% 90d: +830.93%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (37%)
Quality Score
33/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$0.12 – $6.21
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$45.17
+762.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.70 / $7.98
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ATYR is down 34.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When ATYR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ATYR is currently trading at $4.96, which is considered slightly high relative to its 30-day fair value range of $0.12 to $6.21.

Technical Outlook: Technically, ATYR is in a uptrend. Immediate support is located at $4.70, while resistance sits at $7.98. Short-term momentum is weak, with the stock down 5.3% recently.

Market Sentiment: ATYR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $45.17 (+762.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $0.12 - $6.21
Company Quality Score 33/100 (SELL)
Volume Confirmation HIGH
Confidence Score 36.8%

Trading Range & Key Levels

30-Day Trading Range $0.12 - $6.21
Current vs Trading Range SLIGHTLY HIGH
Support Level $4.70
Resistance Level $7.98
Current Trend Uptrend
Technical data as of Nov 17, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Technical Setup Structure MONITORING
Absorption: Inactive (CMF 0.34)
Pullback / Drawdown: -30.9% from 52W High
Consolidation: Trending (ADX 64.7)

Quantitative Signal Breakdown

  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-5.3%)
  • BULLISH: Trading 762.0% below Wall St target ($45.17)
  • WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.05
Wall Street Target $45.17 (+762.0%)
Share ATYR Analysis

Share this live ATYR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ATYR)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 14, 2026
Daily AI digest
AI Retail Discussion Summary: Moderna's international revenue reached $900 million in the first nine months of 2026, making up about 40% of third-quarter revenue. Moderna earned an operating profit in the third quarter of 2026, but still lost money on operations over the last twelve months.
Key Retail Themes: International revenue growth Profitability
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 17, 2026 2:26 PM ET
Data refreshes hourly during market hours. Next update: 3:26 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ATYR.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
28 analysts
$91 55 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
22 analysts
$266 57 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
22 analysts
$107 49 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 56 HOLD
RAPP
Rapport Therapeutics, In…
STRONG BUY
16 analysts
$64 48 HOLD
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals